(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COVI-FERON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

COVI-FERON

ST13

US500000090624233

Class

5

Filing

90624233

Registration

7265585

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

02/20/2025

Trademark type

Combined

Nice classes

5

Filing date

04/05/2021

Registration date

01/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/09/2024

Last transaction

02/20/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

03

Owner location

Gyeonggi-do, KR

Examiner

GANESH, HARINI

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "COVI-FERON" in black, with the "O" in "FERON" represented by a power button symbol. The vertical notch in the power button symbol is in orange.

Holders and representatives

Holders

Bionote, Inc.

Representatives

Max Vern Amster, Rothstein & Ebenstein LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposestreatment and prevention of coronavirus diseaserespiratory disordersinfectious diseases; Biological preparations for the treatment and prevention of coronavirus diseaserespiratory disordersinfectious diseases; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Clinical diagnostic reagents for medical use; Drugs for medical purposespharmaceutical preparations for the prevention of coronavirus diseaserespiratory disordersinfectious diseases; Pregnancy testing preparations for home use; Preparations in the nature of protein arrays for diagnosing tuberculosis; Vaccines; Adjuvants for use with vaccines; Bacteriological culture mediums; Enzymes for medical purposes; All of the foregoing used for the treatment and prevention of COVID-19

Publications

History of USPTO decisions and trademark events.

33 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/20/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/09/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/24/2023

PUBO

PUBLISHED FOR OPPOSITION

10/24/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/19/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/15/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/15/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/29/2023

GNRT

NON-FINAL ACTION E-MAILED

06/29/2023

CNRT

NON-FINAL ACTION WRITTEN

06/29/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/08/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

12/09/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/21/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/21/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/21/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/21/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/21/2022

GNSL

LETTER OF SUSPENSION E-MAILED

06/21/2022

CNSL

SUSPENSION LETTER WRITTEN

06/21/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/01/2021

GNRT

NON-FINAL ACTION E-MAILED

12/01/2021

CNRT

NON-FINAL ACTION WRITTEN

12/01/2021

DOCK

ASSIGNED TO EXAMINER

11/24/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/13/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/12/2021

NWAP

NEW APPLICATION ENTERED

04/08/2021

Continuous trademark protection

Get notified about every new filing that threatens COVI-FERON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.